Pre-emptive, OCT guided angioplasty of vulnerable, intermediate coronary lesions: a randomized trial - the PECTUS trial

Vrije Universiteit Medisch Centrum0 个研究点目标入组 1,000 人开始时间: 待定最近更新: 2024年4月23日

适应症

试验速览

暂无简介。

•- patients with acute myocardial infarction and residual, non-obstructive CAD, with the possibility of plaque vulnerability.
•- the coronary lesion must be suitable for PCI with a commercially available BVS.

•- Refusal or inability to provide informed consent.
•- < 18 years of age
•- Previous CABG.
•- Indication for revascularization by CABG.
•- Target vessel diameter < 2,5 mm or >4.0 mm
•- Anatomy or lesions unsuitable for OCT catheter crossing or imaging (aorta-ostial lesions, small diameter segment, severe calcifications)
•- Anatomy unsuitable for BVS placement (left main, bifurcation stenting, sidebranch (> 2 mm) involvement).
•- Target lesion is instent restenosis
•- Target lesion is chronic total occlusion
•- Severe kidney disease defined as an eGFR < 30 ml/min.
•- Target lesion in the same vessel as the treated culprit lesion
•- Target lesion in the same segment as a previously implanted stent/scaffold
•- Estimated life expectancy < 1 year

发起方